WO2022038235A1 - Procédé pour produire un implant, implant et utilisation de cet implant pour la reconstruction de parties du corps - Google Patents

Procédé pour produire un implant, implant et utilisation de cet implant pour la reconstruction de parties du corps Download PDF

Info

Publication number
WO2022038235A1
WO2022038235A1 PCT/EP2021/073067 EP2021073067W WO2022038235A1 WO 2022038235 A1 WO2022038235 A1 WO 2022038235A1 EP 2021073067 W EP2021073067 W EP 2021073067W WO 2022038235 A1 WO2022038235 A1 WO 2022038235A1
Authority
WO
WIPO (PCT)
Prior art keywords
container
implant
wall
opening
shells
Prior art date
Application number
PCT/EP2021/073067
Other languages
German (de)
English (en)
Inventor
Dirk Hellekes
Lukas PORAK
Original Assignee
Dirk Hellekes
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dirk Hellekes filed Critical Dirk Hellekes
Publication of WO2022038235A1 publication Critical patent/WO2022038235A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/58—Materials at least partially resorbable by the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/18—Internal ear or nose parts, e.g. ear-drums
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/18—Internal ear or nose parts, e.g. ear-drums
    • A61F2/186—Nose parts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/30—Joints
    • A61F2/30756—Cartilage endoprostheses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/30—Joints
    • A61F2/3094—Designing or manufacturing processes
    • A61F2/30942—Designing or manufacturing processes for designing or making customized prostheses, e.g. using templates, CT or NMR scans, finite-element analysis or CAD-CAM techniques
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B33—ADDITIVE MANUFACTURING TECHNOLOGY
    • B33Y—ADDITIVE MANUFACTURING, i.e. MANUFACTURING OF THREE-DIMENSIONAL [3-D] OBJECTS BY ADDITIVE DEPOSITION, ADDITIVE AGGLOMERATION OR ADDITIVE LAYERING, e.g. BY 3-D PRINTING, STEREOLITHOGRAPHY OR SELECTIVE LASER SINTERING
    • B33Y50/00—Data acquisition or data processing for additive manufacturing
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B33—ADDITIVE MANUFACTURING TECHNOLOGY
    • B33Y—ADDITIVE MANUFACTURING, i.e. MANUFACTURING OF THREE-DIMENSIONAL [3-D] OBJECTS BY ADDITIVE DEPOSITION, ADDITIVE AGGLOMERATION OR ADDITIVE LAYERING, e.g. BY 3-D PRINTING, STEREOLITHOGRAPHY OR SELECTIVE LASER SINTERING
    • B33Y80/00—Products made by additive manufacturing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/0059—Cosmetic or alloplastic implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/18—Internal ear or nose parts, e.g. ear-drums
    • A61F2002/183—Ear parts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/30—Joints
    • A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
    • A61F2002/30003—Material related properties of the prosthesis or of a coating on the prosthesis
    • A61F2002/3006—Properties of materials and coating materials
    • A61F2002/30062—(bio)absorbable, biodegradable, bioerodable, (bio)resorbable, resorptive
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/30—Joints
    • A61F2/30767—Special external or bone-contacting surface, e.g. coating for improving bone ingrowth
    • A61F2002/3092—Special external or bone-contacting surface, e.g. coating for improving bone ingrowth having an open-celled or open-pored structure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/30—Joints
    • A61F2/3094—Designing or manufacturing processes
    • A61F2/30942—Designing or manufacturing processes for designing or making customized prostheses, e.g. using templates, CT or NMR scans, finite-element analysis or CAD-CAM techniques
    • A61F2002/30948—Designing or manufacturing processes for designing or making customized prostheses, e.g. using templates, CT or NMR scans, finite-element analysis or CAD-CAM techniques using computerized tomography, i.e. CT scans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/30—Joints
    • A61F2/3094—Designing or manufacturing processes
    • A61F2/30942—Designing or manufacturing processes for designing or making customized prostheses, e.g. using templates, CT or NMR scans, finite-element analysis or CAD-CAM techniques
    • A61F2002/30957—Designing or manufacturing processes for designing or making customized prostheses, e.g. using templates, CT or NMR scans, finite-element analysis or CAD-CAM techniques using a positive or a negative model, e.g. moulds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/30—Joints
    • A61F2/3094—Designing or manufacturing processes
    • A61F2002/30975—Designing or manufacturing processes made of two halves
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/30—Joints
    • A61F2/3094—Designing or manufacturing processes
    • A61F2002/30985—Designing or manufacturing processes using three dimensional printing [3DP]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2240/00—Manufacturing or designing of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2240/001—Designing or manufacturing processes
    • A61F2240/005—Templates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0014—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
    • A61F2250/003—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in adsorbability or resorbability, i.e. in adsorption or resorption time
    • A61F2250/0031—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in adsorbability or resorbability, i.e. in adsorption or resorption time made from both resorbable and non-resorbable prosthetic parts, e.g. adjacent parts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/06—Materials or treatment for tissue regeneration for cartilage reconstruction, e.g. meniscus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/14—Materials or treatment for tissue regeneration for ear reconstruction or ear implants, e.g. implantable hearing aids

Definitions

  • the present invention relates to a method for providing an implant for a patient, in particular an implant with vital cartilage, tissue and/or bone, with the features of patent claim 1, an implant for a patient with the features of patent claim 20 and the use of the implant for the reconstruction of a body part, in particular a human ear or a nasal septum, with the features of patent claim 30.
  • Trauma or tumor diseases can lead to a loss of a patient's tissue structures that contain cartilage structures that provide the shape. Such structures can also be absent due to the nature of the system. Ears and nose, for example, are parts of the body that are formed by cartilage structures that give shape. A loss or absence of these body parts can lead to a significant impairment of the patient, which is why there is an effort, particularly in head and neck surgery, to replace the loss or the hereditary absence of these body parts with reconstructions.
  • the missing tissue can be replaced by various measures, the tissue being brought into a permanent, required form which can correspond to the lost tissue.
  • cartilage-supported and skin-covered areas are reached by a skin covering of the transplanted cartilage and parts of the body parts, especially noses and ears, up to a complete reconstruction.
  • One method known in the art involves harvesting a block of tissue, for example by harvesting costal cartilage.
  • the block of tissue is formed into a suitable cartilage implant by “carving”, with the implant formed in this way having an inherent stability and, if necessary, being reinforced and joined by thread material or supporting structures.
  • a disadvantage of this method known from the prior art has been shown to be that the shaping of the implant requires a great deal of time and that the implant produced has a low degree of precision and therefore does not meet the individual needs of the patient.
  • the enormous amount of time required to shape the implant lengthens the surgical intervention and entails corresponding health risks.
  • the "carving" procedure which can also be understood as a subtractive procedure, has also shown that the success of an intervention depends to a large extent on the practice of the staff and significant amounts of potential donor material accumulate as waste.
  • cartilage-fibrin implant During the implantation of the cartilage-fibrin implant, no pressure forces must act on the cartilage-fibrin implant, otherwise unintentional changes in shape and injuries may occur.
  • the cartilage-fibrin implant also has the disadvantage of only having a low support function, which is why there is an increased risk of injury and the goal pursued with the surgical intervention is missed.
  • the method should enable precise shaping of the body part to be reconstructed, enable a reduction in the duration of the operation and increase process reliability.
  • a temporary support function of the cartilage reconstruction should also be realized in order to ensure the continued success of the surgical intervention.
  • the inventive method for providing an implant tates for a patient, in particular an implant with vital cartilage, tissue and / or bone, with the features of claim 1 is characterized in that a three-dimensional digital model of a container with a lumen enclosed by a wall and a closable opening is generated.
  • the digital model of the container can be a CAD model known from the prior art, which can be stored on a digital storage medium based on data.
  • the closable container is formed from a biodegradable material in an additive process, with the wall of the container being diffusible at least in sections.
  • biodegradable material includes all materials that are biologically degradable in the human body and can be broken down by biological processes in the human body.
  • a patient in connection with this invention can be a human being or another living being, in particular a horse, dog or the like.
  • the lumen in the container is filled, in particular with vital tissue, vital cartilage and/or vital bone, and in a further process step the opening is closed by a closure or a lid so that the filling of the Lumens loss-proof enclosed in the lumen.
  • the diffusible wall is preferably configured in such a way that the filling cannot escape from the lumen through the wall.
  • the present invention is based on the idea of providing an implant for a patient, which can be designed to be individually adapted to the patient and his/her anatomy and, in addition, a container can be prefabricated in advance of a surgical intervention to reconstruct a part of the patient's body.
  • the prefabrication of the container saves time, since the filling of the container, in particular the vital tissue, cartilage and/or bone, does not have to be shaped in a complex manner. This can shorten the duration of the operation.
  • a temporary support function of the implant is also ensured by the method according to the invention, as a result of which high precision is ensured and the reconstructed body part is less sensitive to the effects of force during the healing process.
  • the proposed method also offers the advantage that the quality of the formed reconstruction or implant is less dependent on the practice of the staff and, moreover, the removal of material for filling can be designed more precisely and efficiently.
  • the body part in the context of this invention can be a complete body part or a partial area of a body part, in particular a cartilaginous partial area or a cartilaginous Be part of .
  • the body part can be an ear or an outer ear, an auricle or components thereof such as helix, antihelix auriculae, tragus, antitragus, triangular fossa, scapha, etc. or parts thereof.
  • the body part can also be the nose or parts of the nose, e.g. B. septum, alar or triangular cartilage or the like.
  • a body part can be understood to mean any partial area of a body that can be reconstructed using an implant according to the invention.
  • the three-dimensional digital model is generated using parameter input and/or a 3D scan.
  • a reconstruction of the body part for example a septum of a nose, i.e. a so-called neoseptum
  • aesthetic aspects and ideas of the patient in addition to the anatomical requirements when designing the reconstruction can be included.
  • the digital model can be created generatively or be generated algorithmically or using CAD models.
  • Such a parameter input can be understood as parametric modeling, which includes the logical connection of geometric elements. It can also be possible to record the shape of the body part to be reconstructed by means of a scan or 3D scan or a simulation.
  • the ears the opposite ear of the patient be the basis for the digital model of the container.
  • parts of the container can also be rithms are generated.
  • the diffusible constituents or sections can be created by an appropriate algorithmic manipulation of an originally closed surface.
  • the digital model can also be generated by free CAD drawing, for example the model can be created using images from an imaging process, e.g. B. an MRI , can be generated .
  • images from an imaging process e.g. B. an MRI
  • a corresponding image from the MRT can be used for the construct when creating the model digitally.
  • a corresponding data processing or data manipulation can use the data of the digital model for the body part to be reconstructed or convert ear .
  • the three-dimensional model is scaled, as a result of which, for example, the resorption of the biodegradable material used is taken into account. Due to the resorption of the biodegradable material used, the implant "shrinks" over time until the container is completely absorbed. It can therefore be advantageous to take the resorption into account when generating the three-dimensional model, which is exactly reproduced in the additive process to achieve the best possible aesthetic result .
  • a further development of the method according to the invention provides that when the sealable container is produced, the wall is produced with an opening section surrounding the opening and a wall section, the wall section being configured to permit diffusion through the wall by means of a perforation.
  • the opening section can be diffusion-tight.
  • the perforation is formed by a lattice structure, a network structure and/or a hole structure, each with a plurality of perforation openings, the wall having an open area of 10% to 90% and/or a width of each perforation opening is ⁇ 5 mm.
  • the open area is preferably approx. 25% - 75% and even more preferably approx.
  • the open area describing the ratio between the area blocked by the wall and the area of the perforation openings. With an open area of 0%, the wall is completely closed. When choosing the open area, it is important to remember that the open area should be as large as possible to ensure maximum diffusion and nutrient supply while maintaining mechanical integrity.
  • the opening section forms a reinforcement surrounding the opening.
  • the stiffening of the opening section is characterized in that the stiffness of the stiffening is greater than a corresponding segment of the wall, with the stiffness preferably being at least twice as great as the stiffness of a corresponding segment of the wall.
  • a strapping reinforcement is understood to mean a reinforcement which preferably completely surrounds the opening. Further reinforcements can be provided in order to specifically improve the support function of the implant.
  • the opening section is designed during manufacture of the container in such a way that two wall sections are arranged at a distance from one another on opposite sides of the container.
  • the opening section or The stiffening in the opening section can set a constant distance between the two opposite wall sections in a circumferential direction or specify a variable distance.
  • a further advantageous implementation of the method provides that the container is cleaned and/or sterilized before filling.
  • the container is made available and sterilized before the operation.
  • the container is preferably made available before the operation and sterilized by gas sterilization, preferably using ethylene oxide, with the sterilization lasting between 6-12 hours in order to achieve hygienic conditions.
  • the container can, for example, be reserved for the OP in a sterile environment, in particular in a packaging container, but it is also possible to provide and sterilize the container ad hoc during the OP due to necessary changes using the additive method. Even in the event of unforeseeable complications, a container for the implant that is individually adapted to the patient can be provided in order to be able to carry out the reconstruction of the body part. It can also be advantageous if several containers with different parameters or Sizes are provided in particular before the surgical intervention. If changes are required, a suitable container can be used without significant delay.
  • the container is formed from two half-shells and that the two half-shells can be connected.
  • the two half-shells can be easily filled with the filling, in particular with the vital cartilage, the vital Bone and / or the vital tissue, stocked or. be filled .
  • the two half-shells can be connected at the respective opening section, with the opening section preferably being arranged in a sectional plane of the container which has the largest area.
  • the two half-shells can be connected frictionally, non-positively, materially and/or positively, with the two half-shells preferably being able to be plugged together. Accordingly, one of the two half-shells forms a cover or closure for the opening of the other.
  • individual half-shells with different parameters or Sizes are provided in order to have a choice during the surgical procedure, whereby a suitable container can be assembled without significant delays.
  • the two half-shells can be connected by a seam, in particular a surgical seam made of a more preferred biodegradable suture material.
  • the two half-shells can be produced in the connected state.
  • the two half-shells can be manufactured separately from one another, with production-related advantages being associated in particular with the creation of the two half-shells in the connected state.
  • a development of the present method provides that vital cartilage tissue, vital tissue or vital bone is removed from the patient before the container is filled.
  • the vital cartilage tissue, the vital tissue and/or the vital bone can, for example, come from the inside of the nose, the opposite ear or from the rib region, but is this list is not complete and exhaustive. Rather, tissue, cartilage, bones, but also individual cells or stem cells can be removed from the patient's body and filled into the container.
  • a bone can be reconstructed using a container filled with bone, which bone can be obtained from the traumatized bone, or from any other bone in the patient.
  • the tissue, the cartilage and/or the bone can also be removed from a donor, corresponding to an allotransplantation.
  • the filling in particular the cartilage, bone or tissue, is comminuted, with the comminuted pieces preferably being larger than the perforations in the wall in order to prevent the filling from being accidentally lost from the container .
  • Fibrin glue may be applied to the cartilage, tissue and/or bone to improve the internal adherence of the pieces of cartilage, tissue and/or bone.
  • the implant is ready for implantation in the patient and can be implanted in the patient.
  • the implant can preferably be fixed in a body cavity or body opening in the region of the patient's body part to be reconstructed, biodegradable thread material preferably being used for the fixation.
  • the fixation can be done either with a surgical suture through the perforated tion breakthroughs in the wall, or fastening means can be provided on the container, which enable such a fixation.
  • the fastening means can, for example, comprise eyelets, loops or the like, which protrude from the wall of the container and are formed integrally with the container in the additive manufacturing process.
  • a biodegradable polymer, a biodegradable plastic, a biodegradable tissue or a curable cell suspension is used to form the container.
  • a polylactide (PLA) or Polylactic acid are used, which is a biodegradable polyester and can be obtained from polymerized monomer lactic acid.
  • PLA can also be used as PLA mixtures, also in connection with other materials or material mixtures.
  • Polyhydroxy fatty acids (PHF) can also be used.
  • the best-known representatives are polyhydroxybutyrate (PHB) and polyhydroxyvalerate (PHV).
  • PDS poly-p-dioxanone or for the formation of the container.
  • PDS PPDX or PPDO can be used .
  • a material mixture or several components are used to form the container.
  • materials with different degradation times through to permanence are used, with at least one component being biodegradable.
  • a biodegradable material can be combined with metal or other materials, as a result of which different degrees of dimensional stability or partial absorbability of the container or parts thereof can be achieved.
  • An agent can be enclosed in the respective inclusion, the agent containing an active substance, for example.
  • Another aspect of the present invention is the use of the method described above and its advantageous developments for the reconstruction of a body part of a patient, preferably human body parts, in particular an auricle or a nasal septum or other cartilaginous parts or partial areas of the nose (e.g. nostrils or triangular cartilage , tip of the nose and/or parts thereof) or the ear or the auricle .
  • a body part of a patient preferably human body parts, in particular an auricle or a nasal septum or other cartilaginous parts or partial areas of the nose (e.g. nostrils or triangular cartilage , tip of the nose and/or parts thereof) or the ear or the auricle .
  • an implant for the reconstruction of a body part of a patient in particular a human body part, in particular an auricle or a nasal septum, in particular for carrying out the method described above and its advantageous developments, having a container with a wall enclosed Lumen and a closable opening, wherein the container is made of a biodegradable material in an additive process, and the wall is at least partially diffusible.
  • the container of the implant are built up in layers, creating a surface precision which, after the implantation of the implant, due to an enlarged surface, promotes resorption of the biodegradable material by the human body.
  • the wall can have an opening section surrounding the opening and a wall section, the wall section having a perforation with at least one, preferably with a plurality of perforation openings.
  • the perforation openings enable gas and/or substance exchange through the perforation openings in the wall, as a result of which the implant filled with vital tissue, vital cartilage and/or vital bone is supplied by the patient's body after implantation.
  • the perforation is formed by a lattice structure, a net structure and/or a hole structure and has an open area of 10% to 90%.
  • An open area of 0% corresponds to a completely closed area.
  • the width of a perforation opening should be less than 5 mm or be smaller than the inserted pieces of vital cartilage, vital tissue and/or vital bone.
  • the opening section has two wall sections spaced apart on two opposite sides of the container.
  • the opening section can surround the two wall sections in one keep running direction at a constant distance or the distance can specify any desired distance between the two wall sections arranged on opposite sides in the direction of circulation.
  • the container can be formed from two half-shells, the two half-shells each having a wall section and an opening section, and being connectable at the respective opening section.
  • the two half-shells together enclose a lumen, whereby the two half-shells can be easily filled with a filling.
  • the filling can also be provided with fibrin glue, for example, in the two half-shells that form the lumen.
  • the two half-shells forming the container can preferably be connected to one another in a frictional, form-fitting, non-positive and/or material-locking manner, with the two half-shells preferably being able to be plugged together.
  • the opening of the container is closed by the friction, positive, non-positive and/or material connection between the two half-shells.
  • the two half-shells can wedge and thus form a resilient connection.
  • a reinforcement surrounding the opening is provided.
  • the stiffness of the reinforcement is preferably greater than a corresponding segment of the wall or. of the wall section, the rigidity preferably being at least twice as great as the rigidity of a corresponding segment of the wall.
  • the stiffening can in particular form corresponding plug-in areas that can engage in one another.
  • the container is polygonal, in particular triangular, circular, oval or shell-shaped. In a preferred embodiment, the container is triangular and the circumferential end faces form the opening section or. the stiffening with the plug-in area, while the opposite main surfaces form the diffusible wall.
  • the polygonal shape can be modeled on the shape of a nose, with the outer circumference being designed according to patient-specific parameters.
  • the stiffening or the opening sections form a supporting frame, which is modeled, for example, on the shape of the bridge of the nose, a tip of the nose and a bridge of the nose of the patient in a reconstruction.
  • a development of the present invention provides that the container is designed in the shape of a torus.
  • the two half-shells of the toroidal container can be shell-shaped.
  • An opening in the toroidal container can form the auditory canal, for example, in the case of an implant for the reconstruction of an ear.
  • At least one inclusion can be provided in the wall of the container.
  • the at least one inclusion in the container can be arranged at a predetermined distance from an outside and/or an inside of the wall, as a result of which the at least one inclusion in the container is uncovered after implantation during biodegradation at a specified point in time.
  • a plurality of inclusions can preferably be provided, which are distributed on the one hand over the wall of the container can, and can also be arranged at different distances from the inside and/or the outside.
  • An agent in particular a drug, which can contain an active substance, can be provided in the at least one inclusion.
  • the agent can, for example, promote wound healing or prevent a rejection reaction of the patient's body.
  • the rejection reaction of the patient's body can thus be prevented until the foreign body, namely the container made of a biodegradable material, has decomposed.
  • An implant designed in this way combines a support function with a (medicinal) agent delivery system.
  • the container produced in the additive process is made from a biodegradable plastic, tissue and/or from a cell suspension.
  • the material used for the container is completely resorbed or absorbed by the human body. can be degraded, whereby no residues of the container of the implant remain on the body part of the patient after complete biodegradation.
  • a further aspect of the present invention relates to the use of the implant described above and its preferred developments for the reconstruction of a human body part and/or a cartilage-supported structure, in particular an auricle or a nasal septum.
  • FIG. 1 shows a schematic and perspective representation of a container of an implant for the reconstruction of a septum
  • FIG. 2 shows a side view of the container according to FIG. 1,
  • FIG. 3 shows a sectional view of the container along the section line A-A according to FIG. 2, with a lumen in the container being filled with a filling,
  • FIG. 4 shows an exploded view of the container according to FIGS. 1-3, with a lumen in the container being filled with a filling
  • FIG. 5 shows a schematic and greatly simplified illustration of a container, which is designed in the shape of a torus, for an implant for the reconstruction of an ear and
  • FIG. 6 shows a schematic and highly simplified representation of the method for providing an implant, in particular an implant with vital cartilage, tissue and/or bone, for a patient.
  • FIG. 1 shows a container 2 of an implant 1, which can be used for the reconstruction of a part of a patient's body, in particular a septum.
  • the container 2 according to FIGS. 1-5 is produced in an additive process, for example by means of 3D printing, and can be produced layer by layer during the additive manufacturing process.
  • the container 2 is made from a biodegradable material, which can be degraded in the patient by biological processes, preferably completely and without residues.
  • the container 2 can be made of poly-p-dioxanone, for example, with this material being characterized in that it can be produced in an additive manufacturing process, such as free-jet binder application, material application with directed energy input, material extrusion, free-jet material application, powder-bed-based Melting, layer lamination and bath-based photopolymerization is processable.
  • the device used to produce the container 2 can produce the container 2 from a digital model, preferably from a three-dimensional model, CNC (Computerized Numerical Control) with high precision.
  • the container 2 comprises a wall 10 which encloses a lumen 15 .
  • the container 2 has a closable opening 20 through which a filling can be introduced into the container 2 .
  • the opening 20 can be closed by a closure or cover.
  • the wall 10 of the container 2 is at least partially formed diffusible, whereby a substance f exchange - like will be described later in detail - can take place between the lumen 15 and an area surrounding the container 2 through the wall 10 .
  • the wall 10 can be divided into an opening section 12 and a wall section 14, with the opening section 12 being arranged around the opening 20 and being non-diffusible and the wall section 14 being diffusible.
  • the opening section 12 can be designed as a reinforcement 13 which is characterized in that the rigidity of the reinforcement 13 is greater than a corresponding segment of the wall section 14 .
  • the reinforcement 13 encircles the opening 20 and on the one hand forms a stable support structure for the container 2 and enables the opening 20 of the container 2 to be securely closed. Additional stiffeners 13 can be formed at any point on the container 2 .
  • the wall section 14 has a perforation 40 which is formed from a plurality of perforation openings 45 .
  • the perforation 40 can be formed by perforation openings 45 of any configuration, with the perforation 40 being formed by a lattice structure according to the exemplary embodiment shown.
  • the perforation 40 can also have a network structure and/or a hole structure.
  • the perforation openings 45 can be arranged in such a way that the wall section 14 has a relative open area A o of A o *50%.
  • the open area A o can be made arbitrarily large or small as long as a width of the perforation openings 45 does not exceed a value that would allow the filling in the lumen 15 to exit the lumen 15 through the perforation openings 45 .
  • the width of the perforation openings 45 is at most 5 mm.
  • Each of the two half-shells 21 , 22 has a wall section 14 and an opening section 12 , the two half-shells 21 , 22 being able to be fitted together in the opening sections 12 .
  • One of the two half-shells 21, 22 forms a cover for the opening 20 of the respective other half-shell 21, 22.
  • the opening sections 12--as can be seen in particular from FIG. In the assembled state of the two half-shells 21, 22, the opening sections 12 or the mutually corresponding plug-in areas 16 wedge, whereby the two half-shells 21, 22 can be connected to each other.
  • the two half-shells 21, 22 can be connected to one another by means of a positive, non-positive and/or material connection. It is also conceivable to connect the two half-shells 21, 22 by means of a snap-in closure and/or by means of an adhesive connection.
  • the shape of the container 2 can be designed as desired.
  • the Container 2 can be approximately triangular in shape and thus be modeled on the shape of a patient's nose.
  • the exact shape of the container 2 can be patient-specific, with the digital model of the container 2 being formed either by entering a large number of values or parameters or by measuring the patient.
  • the model can be manipulated at will in order to take account of the patient's individual wishes or ideas.
  • simulations can be used to generate the model of the container 2 in order to illustrate the desired reconstruction result and to be able to make adjustments.
  • the side surfaces of the container 2 are formed by the circumferential opening section 12 with the stiffening 13
  • the main surfaces of the wall 10 are designed as a wall section 14 capable of diffusion.
  • FIG. 5 shows a first half shell 21 of a container 2 for the reconstruction of a human ear.
  • the shape of the half-shell 21 of the container 2 can be approximately described as shell-shaped, with the container 2 having a toroidal opening which is later to form an auditory canal for the patient.
  • the container 2 according to FIG. 5 can be designed analogously to the container 2 according to FIGS. 1-4 and the lumen 15 in the container 2 can be closed by connecting the two shell-shaped half-shells 21 , 22 .
  • the wall sections 14 of the two half-shells 21, 22 can have different shapes in order to be able to reproduce the body part to be reconstructed in detail.
  • the container can be designed according to an exemplary embodiment described above and have a wall 10 which is designed to be diffusible at least in sections and which encloses a closable lumen 15 .
  • a digital model of the container 2 is generated.
  • the digital model can be generated in any way.
  • various parameters can be used for a reconstruction of a septum, a so-called neoseptum, in order to describe the shape of the bridge of the nose, the tip of the nose and the bridge of the nose.
  • the properties, in particular for the functional wall, of the container can be generated generically, it also being possible to use parameters for the generic generation, in order to specify, for example, the open area and the maximum width of an opening.
  • the opposite ear of the patient can serve as a model for an implant 1 for the reconstruction of an ear.
  • the digital model for the container 2 of the implant 1 can be derived, for example, from a 3D scan, with the data being converted, transformed and/or scaled by appropriate data manipulation or data processing in order to create a digital model suitable for the reconstruction of the respective body part provide a container 2 .
  • Method step 120 of the container 2 using a biodegradable material are produced in an additive process.
  • the two half-shells 21 , 22 of the container 2 can be manufactured in the detachable and connected state or separately, in which case manufacturing in the detachable and connected state can offer manufacturing advantages. For example, with powder-based melting, a smaller powder pool can be used and/or the manufacturing process takes less time.
  • At least one inclusion can be formed in the wall 10 of the container 2 during the additive manufacturing of the container 2 .
  • the inclusion can be arranged in the wall 10 of the container 2 precisely at predetermined positions between an inside facing the lumen 15 and an outside facing away from the lumen 15, whereby the inclusion is exposed at a predetermined point in time during subsequent biodegradation in the patient.
  • an active substance which promotes wound healing or prevents a rejection reaction of the patient's body can be arranged in the inclusion. It goes without saying that a large number of inclusions can be arranged at different positions in the wall 10 of the container 2, as a result of which one or more active substances can be released in a targeted manner over a period of time.
  • the container 2 can be cleaned and/or sterilized.
  • Method steps 110 and 120 can be carried out in advance of an operation. suitable for surgery or The container 2 can be provided sterile for the OP, resulting in a time saving in the OP due to this prefabrication.
  • the lumen 15 of the container 2 is filled, with the container 2 preferably being able to be filled with vital tissue, vital cartilage and/or vital bone, as shown in FIG. 4 . At least one of the half-shells 21, 22 can be filled.
  • the vital tissue, vital cartilage and/or vital bone can be removed from the patient (autotransplantation) or from a suitable donor (allotransplantation), with the cartilage tissue, for example, being taken from uninjured areas of the patient's body, in particular from the inside of the nose, the opposite ear or from can be taken from the rib region.
  • the vital tissue, the vital cartilage and / or the vital bone can, respectively. can be crushed either mechanically or manually, the pieces formed during crushing should not be smaller than the width of the perforation openings 45 . This ensures that the reduced pieces cannot escape from the lumen 15 of the container 2 through the perforation openings 45 .
  • the container 2 or. the lumen 15 is filled with the vital tissue, vital cartilage and/or the vital bone, it being possible for the vital tissue, the vital cartilage and/or the vital bone to be provided with a fibrin glue both before and after the filling of the container 2 , to check the inner adherence of the particles resp. to improve cartilage bits .
  • the two half-shells 21, 22 can each be filled, or only one of the two half-shells 21, 22.
  • the opening 20 of the container 2 is closed.
  • the two half-shells 21, 22 as described in the exemplary embodiments with reference to FIGS. 1-5—the two half-shells 21, 22 can be plugged together.
  • a cover of any design can be placed on the opening in order to close the opening.
  • the two half-shells 21, 22 can also be connected to one another by means of a material connection, in which case fibrin glue can be used, for example, in order to bring about a material connection between the two half-shells 21, 22.
  • the lid with the container 2 or the two half-shells 21, 22 are connected to one another by a seam, in which case a biodegradable suture material should be used.
  • FIG. 5 shows a sectional representation of a closed container 2 filled with pieces of cartilage.
  • the container 2 or the implant 1 according to FIG. 1-5 for the reconstruction of a nose forms a neoseptum, which can be positioned in the patient between divided bands of mucous membrane of the nose.
  • the implant 1 can be fixed by means of sutures, which can also be made of biodegradable suture material.
  • the lumen 15 in the container 2 provides passive support for the vital tissue 15, the vital cartilage and/or the vital
  • the implant 1 according to FIGS. 1-4 can offer a protective function for the nose vertically and horizontally and at the same time keep the filling of the lumen 15 in a protected position until the body part or the neoseptum is ingrown.
  • the vital tissue, the vital cartilage and/or the vital bone can be nourished early by diffusion and the later ingrowth of blood vessels is possible.

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Otolaryngology (AREA)
  • Manufacturing & Machinery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Materials Engineering (AREA)
  • Rheumatology (AREA)
  • Geometry (AREA)
  • Physics & Mathematics (AREA)
  • Prostheses (AREA)
  • Materials For Medical Uses (AREA)

Abstract

L'invention concerne un procédé pour produire un implant (1) pour un patient, en particulier un implant (1) comportant du cartilage, des tissus ou des os vivant(s), comprenant un modèle numérique tridimensionnel d'un contenant (2) présentant une lumière (15) entourée par une paroi (10) et une ouverture (20) fermable, caractérisé en ce qu'il consiste à former le contenant (2) fermable à partir d'un matériau biodégradable lors d'un procédé additif, la paroi (10) étant conçue, au moins dans certaines zones, de manière à permettre une diffusion ; à remplir le contenant (2), en particulier avec du cartilage, des tissus ou des os vivant(s) et à fermer l'ouverture (20) du contenant (2). Cette invention concerne en outre un implant (1) ainsi que l'utilisation de cet implant (1) pour la reconstruction d'une partie de corps d'un patient.
PCT/EP2021/073067 2020-08-19 2021-08-19 Procédé pour produire un implant, implant et utilisation de cet implant pour la reconstruction de parties du corps WO2022038235A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102020121761.7 2020-08-19
DE102020121761.7A DE102020121761B3 (de) 2020-08-19 2020-08-19 Verfahren zur Bereitstellung eines Implantats sowie Implantat

Publications (1)

Publication Number Publication Date
WO2022038235A1 true WO2022038235A1 (fr) 2022-02-24

Family

ID=77726437

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2021/073067 WO2022038235A1 (fr) 2020-08-19 2021-08-19 Procédé pour produire un implant, implant et utilisation de cet implant pour la reconstruction de parties du corps

Country Status (2)

Country Link
DE (1) DE102020121761B3 (fr)
WO (1) WO2022038235A1 (fr)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1561481A2 (fr) * 2004-02-09 2005-08-10 DePuy Mitek, Inc. échafaudage contenant du tissu viable
CN106031800A (zh) * 2015-03-08 2016-10-19 中南大学湘雅三医院 一种诱导软骨/骨组织再生成型的中空支架
EP3120796A1 (fr) * 2015-07-17 2017-01-25 Mimedis AG Procédé et système pour la production d'un implant
EP3673873A1 (fr) * 2017-04-21 2020-07-01 Warsaw Orthopedic, Inc. Impression 3d de greffons osseux

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4430760A (en) 1981-12-18 1984-02-14 Collagen Corporation Nonstress-bearing implantable bone prosthesis
US20050064042A1 (en) 2003-04-29 2005-03-24 Musculoskeletal Transplant Foundation Cartilage implant plug with fibrin glue and method for implantation
EP3072465B1 (fr) 2009-09-10 2020-04-08 Woodwelding AG Dispositif destiné à être implanté dans un corps humain ou animal pour remise de matériel à l'intérieur du corps
US20120116515A1 (en) 2010-10-25 2012-05-10 Semler Eric J Demineralized cortical bone implants
US10624727B2 (en) 2014-06-26 2020-04-21 Ipengine Management (India) Private Limited Medical implants and fabrication of medical implants
WO2018017611A1 (fr) 2016-07-18 2018-01-25 Cook Biotech Incorporated Poche implantable à structure stratifiée segmentaire.

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1561481A2 (fr) * 2004-02-09 2005-08-10 DePuy Mitek, Inc. échafaudage contenant du tissu viable
CN106031800A (zh) * 2015-03-08 2016-10-19 中南大学湘雅三医院 一种诱导软骨/骨组织再生成型的中空支架
EP3120796A1 (fr) * 2015-07-17 2017-01-25 Mimedis AG Procédé et système pour la production d'un implant
EP3673873A1 (fr) * 2017-04-21 2020-07-01 Warsaw Orthopedic, Inc. Impression 3d de greffons osseux

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
DATABASE EPODOC [online] EUROPEAN PATENT OFFICE, THE HAGUE, NL; XP002804926, Database accession no. CN-201510099776-A *
DATABASE WPI Week 201679, Derwent World Patents Index; AN 2016-69141C, XP002804925 *
LIAO JUNLIN ET AL: "Auricle shaping using 3D printing and autologous diced cartilage", THE LARYNGOSCOPE, vol. 129, no. 11, 7 March 2019 (2019-03-07), United States, pages 2467 - 2474, XP055868723, ISSN: 0023-852X, Retrieved from the Internet <URL:https://onlinelibrary.wiley.com/doi/full-xml/10.1002/lary.27752> DOI: 10.1002/lary.27752 *
SWAROOP GAMBHIR SINGH ET AL: "Autogenous control augmentation system - A refinement in diced cartilage glue graft for augmentation of dorsum of nose", INDIAN JOURNAL OF PLASTIC SURGERY, vol. 51, no. 02, 1 May 2018 (2018-05-01), pages 202 - 207, XP055868738, ISSN: 0970-0358, DOI: 10.4103/ijps.IJPS_69_18 *

Also Published As

Publication number Publication date
DE102020121761B3 (de) 2022-02-03

Similar Documents

Publication Publication Date Title
EP1208410B1 (fr) Procede pour la generation d&#39;implants specifiques aux patients
EP3244937B1 (fr) Procédé pour la fabrication d&#39;un chapeau d&#39;un dispositif de recouvrement pour un site de défaut osseux, et dispositif pour le recouvrement et/ou la reconstruction d&#39;un site de défaut osseux
EP0502349B1 (fr) Procédé pour fabriquer un implant avec une structure métallique à pores ouverts recouvrant au moins partiellement sa surface
DE19953771C1 (de) Resorbierbares Knochen-Implantatmaterial sowie Verfahren zur Herstellung desselben
EP2536446B1 (fr) Dispositif pour le recouvrement et/ou la reconstruction d&#39;un défaut d&#39;un os, et son procédé de fabrication
DE102010020608A1 (de) Biokompatible Hülle für eine Knochenbehandlung
DE102014008476A1 (de) Herstellung einer Komponente zur Züchtung eines Gelenkflächenimplantats, Züchtung und Implantation eines Gelenkflächenimplantats
DE9115341U1 (de) Stützgitter zur Aufnahme von partikulären Knochenersatzmaterialien
DE68906856T2 (de) Perkutanes Implantat.
EP3294222B1 (fr) Dispositif pour le recouvrement et/ou la reconstruction d&#39;un défaut d&#39;un os et procédé de fabrication d&#39;un couronnement d&#39;un dispositif de recouvrement pour un défaut d&#39;un os
DE102020121761B3 (de) Verfahren zur Bereitstellung eines Implantats sowie Implantat
DE102015107599A1 (de) Flächiges Knochenersatzmaterial und Verfahren zur Herstellung eines porösen Körpers
WO2016180397A1 (fr) Dispositif pour le recouvrement et/ou la reconstruction d&#39;un défaut d&#39;un os et procédé de fabrication d&#39;un couronnement d&#39;un dispositif de recouvrement pour un défaut d&#39;un os
DE10138373A1 (de) Verfahren zum gesteuerten Aufbau eines Knochens und Bohrschablone hierzu
DE102015205538A1 (de) Verfahren zum Herstellen eines Körper-Implantats
DE10006851C2 (de) Verfahren zur Herstellung einer künstlichen Schädelkalotte
Bill et al. Rapid prototyping in planning reconstructive surgery of the head and neck: Review and evaluation of indications in clinical use
DE102021201278A1 (de) Verfahren zum Entwerfen einer Kiefergelenksprothese und entsprechendes Herstellungsverfahren
EP3993731B1 (fr) Dispositif de recouvrement pour un défaut osseux et procédé de fabrication d&#39;un dispositif de recouvrement pour un défaut osseux
EP1096899B1 (fr) Pieces moulees, notamment pellicules, s&#39;utilisant pour favoriser la regeneration de materiau osseux dans la machoire
DE102011087899B4 (de) Gelenkscaffold
WO2020239777A1 (fr) Endoprothèse de poignet
DE202013102439U1 (de) Nasenwandimplantat und Operationsset zur Korrektur einer Knorpelschwäche der menschlichen Nase
AHMAD et al. 3-D-Drucker und Materialien.
EP4342430A1 (fr) Moule pour espaceur d&#39;articulation de doigt

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 21769350

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 21769350

Country of ref document: EP

Kind code of ref document: A1